NEW YORK (360Dx) – Theranos is laying off 155 employees, or 41 percent of its workforce, in order to focus on commercializing its miniLab testing technology, the firm said on Friday.

After the layoffs, Theranos will have 220 employees tasked with product development and regulatory and commercial efforts. In a statement the firm said the decision to trim its operations was difficult. "[H]owever this move allows Theranos to marshal its resources most efficiently and effectively."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.